Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2011 1
2017 1
2019 2
2020 2
2021 3
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
The management of hodgkin lymphomas in pregnancies.
Moshe Y, Bentur OS, Lishner M, Avivi I. Moshe Y, et al. Eur J Haematol. 2017 Nov;99(5):385-391. doi: 10.1111/ejh.12956. Epub 2017 Oct 5. Eur J Haematol. 2017. PMID: 28850718 Review.
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Pemmaraju N, Deconinck E, Mehta P, Walker I, Herling M, Garnache-Ottou F, Gabarin N, Campbell CJV, Duell J, Moshe Y, Mughal T, Mohty M, Angelucci E. Pemmaraju N, et al. Among authors: moshe y. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):e130-e137. doi: 10.1016/j.clml.2023.12.010. Epub 2023 Dec 20. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38267355 Free article. Review.
Venetoclax is safe and efficacious in relapsed/refractory AML.
Ganzel C, Ram R, Gural A, Wolach O, Gino-Moor S, Vainstein V, Nachmias B, Apel A, Koren-Michowitz M, Pasvolsky O, Yerushalmi R, Danylesko I, Cohen Y, Peretz G, Moshe Y, Zektser M, Yeganeh S, Rowe JM, Ofran Y. Ganzel C, et al. Among authors: moshe y. Leuk Lymphoma. 2020 Sep;61(9):2221-2225. doi: 10.1080/10428194.2020.1761964. Epub 2020 May 18. Leuk Lymphoma. 2020. PMID: 32420775
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis.
Shimony S, Canaani J, Kugler E, Nachmias B, Ram R, Henig I, Frisch A, Ganzel C, Vainstein V, Moshe Y, Aumann S, Yeshurun M, Ofran Y, Raanani P, Wolach O. Shimony S, et al. Among authors: moshe y. Ann Hematol. 2022 Sep;101(9):2011. doi: 10.1007/s00277-022-04929-1. Ann Hematol. 2022. PMID: 35869985 No abstract available.
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy.
Barki-Harrington L, Baron-Epel O, Shaulov A, Akria L, Barshay Y, Dally N, Deshet D, Inbar T, Koren-Michowitz M, Leiba M, Moshe Y, Shvidel L, Tadmor T, Yagenah S, Zektser M, Preis M, Hellman I, Yahalom V, Aviv A. Barki-Harrington L, et al. Among authors: moshe y. Palliat Med. 2021 May;35(5):927-932. doi: 10.1177/02692163211000634. Epub 2021 Mar 24. Palliat Med. 2021. PMID: 33761783 Free PMC article.
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.
Fredman D, Moshe Y, Wolach O, Heering G, Shichrur K, Goldberg I, Hofstetter L, Neaman M, Scheib T, Marcu-Malina V, Avigdor A, Shimoni A, Nagler A, Canaani J. Fredman D, et al. Among authors: moshe y. Ann Hematol. 2022 Mar;101(3):581-593. doi: 10.1007/s00277-021-04738-y. Epub 2022 Jan 28. Ann Hematol. 2022. PMID: 35088172
19 results